Form 8-K - Current report:
SEC Accession No. 0001549595-24-000003
Filing Date
2024-01-08
Accepted
2024-01-08 07:03:31
Documents
58
Period of Report
2024-01-08
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nrix-20240108.htm   iXBRL 8-K 30444
2 EX-99.1 nrix-202401088xkex991.htm EX-99.1 50737
3 EX-99.2 nrix-202401088xkex992.htm EX-99.2 34024
7 nrix-202401088xkex991001.jpg GRAPHIC 52576
8 nrix-202401088xkex991002.jpg GRAPHIC 276174
9 nrix-202401088xkex991003.jpg GRAPHIC 105921
10 nrix-202401088xkex991004.jpg GRAPHIC 157640
11 nrix-202401088xkex991005.jpg GRAPHIC 150188
12 nrix-202401088xkex991006.jpg GRAPHIC 120109
13 nrix-202401088xkex991007.jpg GRAPHIC 87944
14 nrix-202401088xkex991008.jpg GRAPHIC 102275
15 nrix-202401088xkex991009.jpg GRAPHIC 88786
16 nrix-202401088xkex991010.jpg GRAPHIC 68231
17 nrix-202401088xkex991011.jpg GRAPHIC 109553
18 nrix-202401088xkex991012.jpg GRAPHIC 111170
19 nrix-202401088xkex991013.jpg GRAPHIC 138010
20 nrix-202401088xkex991014.jpg GRAPHIC 140880
21 nrix-202401088xkex991015.jpg GRAPHIC 141448
22 nrix-202401088xkex991016.jpg GRAPHIC 121226
23 nrix-202401088xkex991017.jpg GRAPHIC 120096
24 nrix-202401088xkex991018.jpg GRAPHIC 110083
25 nrix-202401088xkex991019.jpg GRAPHIC 111213
26 nrix-202401088xkex991020.jpg GRAPHIC 69659
27 nrix-202401088xkex991021.jpg GRAPHIC 102058
28 nrix-202401088xkex991022.jpg GRAPHIC 82596
29 nrix-202401088xkex991023.jpg GRAPHIC 103013
30 nrix-202401088xkex991024.jpg GRAPHIC 130110
31 nrix-202401088xkex991025.jpg GRAPHIC 126608
32 nrix-202401088xkex991026.jpg GRAPHIC 123854
33 nrix-202401088xkex991027.jpg GRAPHIC 97737
34 nrix-202401088xkex991028.jpg GRAPHIC 146178
35 nrix-202401088xkex991029.jpg GRAPHIC 133680
36 nrix-202401088xkex991030.jpg GRAPHIC 121528
37 nrix-202401088xkex991031.jpg GRAPHIC 112190
38 nrix-202401088xkex991032.jpg GRAPHIC 115982
39 nrix-202401088xkex991033.jpg GRAPHIC 108037
40 nrix-202401088xkex991034.jpg GRAPHIC 114122
41 nrix-202401088xkex991035.jpg GRAPHIC 97409
42 nrix-202401088xkex991036.jpg GRAPHIC 82041
43 nrix-202401088xkex991037.jpg GRAPHIC 117599
44 nrix-202401088xkex991038.jpg GRAPHIC 83864
45 nrix-202401088xkex991039.jpg GRAPHIC 110482
46 nrix-202401088xkex991040.jpg GRAPHIC 116195
47 nrix-202401088xkex991041.jpg GRAPHIC 116692
48 nrix-202401088xkex991042.jpg GRAPHIC 100930
49 nrix-202401088xkex991043.jpg GRAPHIC 122039
50 nrix-202401088xkex991044.jpg GRAPHIC 26669
  Complete submission text file 0001549595-24-000003.txt   7128672

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nrix-20240108.xsd EX-101.SCH 1901
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nrix-20240108_lab.xml EX-101.LAB 24851
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nrix-20240108_pre.xml EX-101.PRE 13046
52 EXTRACTED XBRL INSTANCE DOCUMENT nrix-20240108_htm.xml XML 2824
Mailing Address 1700 OWENS STREET, SUITE 205 SAN FRANCISCO CA 94158
Business Address 1700 OWENS STREET, SUITE 205 SAN FRANCISCO CA 94158 (415) 660-5320
Nurix Therapeutics, Inc. (Filer) CIK: 0001549595 (see all company filings)

EIN.: 270838048 | State of Incorp.: DE | Fiscal Year End: 1130
Type: 8-K | Act: 34 | File No.: 001-39398 | Film No.: 24518286
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)